z-logo
open-access-imgOpen Access
Vasopressin antagonist efficacy and safety in volume-overloaded critically ill patients: a new therapeutic alternative
Author(s) -
Jesús Ruiz-Ramos,
Paula Ramírez,
Manel Porcar,
Mónica Gordon,
Esther Villarreal,
Armando Pinos,
M. Meliàn Sosa,
Álvaro Castellanos-Ortega
Publication year - 2018
Publication title -
european journal of hospital pharmacy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.313
H-Index - 14
eISSN - 2047-9964
pISSN - 2047-9956
DOI - 10.1136/ejhpharm-2018-001664
Subject(s) - tolvaptan , medicine , refractory (planetary science) , volume overload , diuretic , observational study , intravascular volume status , diuresis , vasopressin antagonists , anesthesia , vasopressin , intensive care medicine , heart failure , antagonist , renal function , hemodynamics , receptor , physics , astrobiology
To assess tolvaptan's efficacy and safety in critical care patients with volume overload.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here